SLC25A38 and metastatic neoplasm: The mutation of BAP1 was previously reported to be associated with the UM metastasis, but only 50% (13/26) of metastatic tumors presented with BAP1 mutation, whose incidence was also much lower than that of SLC25A38 downregulation.